Sen. Shippey introduces RS 31966, a temporary moratorium on experimental gene-therapy immunizations

Senator Brandon Shippey, of District 9, asked the Senate Health and Welfare Committee to print RS 31966, legislation establishing a temporary moratorium on experimental human gene-therapy products used as immunizations for infectious-disease indications.

"This legislation is named in honor of Doug Cameron, an Idaho rancher whose life was forever changed after receiving a genetic immunization," Shippey said, describing the measure as a pause to allow time for safety and long-term-effect review. He said the bill would "provide the necessary time to evaluate these technologies while protecting our citizens" and asked for committee support to introduce the legislation.

Senator Melissa Wintrow voiced interest in learning exactly what the moratorium would cover and whether the bill would allow exceptions or consent-based uses. Shippey said the bill contains an exemption on the second page and that the committee hearing would include experts to address detailed questions.

Senator Lenny moved to send RS 31966 to print; the motion was seconded and approved by voice vote.

Why it matters: The RS would pause use of specified products as immunizations for infectious-disease indications pending review; sponsors said the pause aims to ensure safety and transparency while lawmakers evaluate long-term effects. A committee hearing will determine the precise scope of the moratorium and any exemptions.

Next steps: RS 31966 was sent to print for introduction; sponsors said they will bring experts to the hearing to clarify scope and exemptions.